Clay B Siegall - Net Worth and Insider Trading
Clay B Siegall Net Worth
The estimated net worth of Clay B Siegall is at least $160 Million dollars as of 2024-12-03. Clay B Siegall is the President & CEO of Seagen Inc and owns about 666,060 shares of Seagen Inc (SGEN) stock worth over $152 Million. Clay B Siegall is the President and CEO of Immunome Inc and owns about 519,636 shares of Immunome Inc (IMNM) stock worth over $7 Million. Clay B Siegall is also the Director of Ultragenyx Pharmaceutical Inc and owns about 2,550 shares of Ultragenyx Pharmaceutical Inc (RARE) stock worth over $121,380. Besides these, Clay B Siegall also holds Alder BioPharmaceuticals Inc (ALDR) . Details can be seen in Clay B Siegall's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Clay B Siegall has not made any transactions after 2024-11-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Clay B Siegall
Clay B Siegall Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Clay B Siegall owns 6 companies in total, including Seagen Inc (SGEN) , Ultragenyx Pharmaceutical Inc (RARE) , and Alder BioPharmaceuticals Inc (ALDR) among others .
Click here to see the complete history of Clay B Siegall’s form 4 insider trades.
Insider Ownership Summary of Clay B Siegall
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SGEN | Seagen Inc | 2022-05-12 | director & President and CEO |
| RARE | Ultragenyx Pharmaceutical Inc | 2020-08-10 | director |
| ALDR | Alder BioPharmaceuticals Inc | 2019-10-22 | director |
 | | 2015-09-30 | director |
| | 2021-05-28 | director |
| | 2024-05-21 | director & President and CEO |
Clay B Siegall Latest Holdings Summary
Clay B Siegall currently owns a total of 4 stocks. Among these stocks, Clay B Siegall owns 666,060 shares of Seagen Inc (SGEN) as of May 12, 2022, with a value of $152 Million and a weighting of 95.3%. Clay B Siegall owns 519,636 shares of Immunome Inc (IMNM) as of November 22, 2024, with a value of $7 Million and a weighting of 4.58%. Clay B Siegall also owns 2,550 shares of Ultragenyx Pharmaceutical Inc (RARE) as of August 10, 2020, with a value of $121,380 and a weighting of 0.08%. The other 1 stocks Alder BioPharmaceuticals Inc (ALDR) have a combined weighting of 0.05% among all his current holdings.
Latest Holdings of Clay B Siegall
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SGEN | Seagen Inc | 2022-05-12 | 666,060 | 228.74 | 152,354,564 |
| IMNM | Immunome Inc | 2024-11-22 | 519,636 | 14.08 | 7,316,475 |
| RARE | Ultragenyx Pharmaceutical Inc | 2020-08-10 | 2,550 | 47.60 | 121,380 |
| ALDR | Alder BioPharmaceuticals Inc | 2015-05-18 | 4,444 | 18.88 | 83,903 |
Holding Weightings of Clay B Siegall
Clay B Siegall Form 4 Trading Tracker
According to the SEC Form 4 filings, Clay B Siegall has made a total of 32 transactions in Seagen Inc (SGEN) over the past 5 years, including 0 buys and 32 sells. The most-recent trade in Seagen Inc is the sale of 17,043 shares on May 12, 2022, which brought Clay B Siegall around $2 Million.
According to the SEC Form 4 filings, Clay B Siegall has made a total of 3 transactions in Immunome Inc (IMNM) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Immunome Inc is the acquisition of 100,000 shares on November 22, 2024, which cost Clay B Siegall around $962,000.
According to the SEC Form 4 filings, Clay B Siegall has made a total of 1 transactions in Ultragenyx Pharmaceutical Inc (RARE) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Ultragenyx Pharmaceutical Inc is the sale of 34,750 shares on August 10, 2020, which brought Clay B Siegall around $3 Million.
More details on Clay B Siegall's insider transactions can be found in the Insider Trading History of Clay B Siegall table.Insider Trading History of Clay B Siegall
- 1
Clay B Siegall Trading Performance
GuruFocus tracks the stock performance after each of Clay B Siegall's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Clay B Siegall is 22.82%. GuruFocus also compares Clay B Siegall's trading performance to market benchmark return within the same time period. The performance of stocks bought by Clay B Siegall within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Clay B Siegall's insider trading performs compared to the benchmark.
Performance of Clay B Siegall
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -1.32 | | | | | |
| Relative Return to S&P 500(%) | -3.01 | | | | | |
Clay B Siegall Ownership Network
Clay B Siegall Owned Company Details
What does Seagen Inc do?
Who are the key executives at Seagen Inc?
Clay B Siegall is the director & President and CEO of Seagen Inc. Other key executives at Seagen Inc include director & Chief Executive Officer David R Epstein , See Remarks Vaughn B Himes , and EVP & Commercial Charles R Romp .
Seagen Inc (SGEN) Insider Trades Summary
Over the past 18 months, Clay B Siegall made no insider transaction in Seagen Inc (SGEN). Other recent insider transactions involving Seagen Inc (SGEN) include a net sale of 36,031 shares made by Vaughn B Himes , a net sale of 1,746 shares made by Charles R Romp , and a net sale of 5,116 shares made by Roger D Dansey .
In summary, during the past 3 months, insiders sold 0 shares of Seagen Inc (SGEN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 63,487 shares of Seagen Inc (SGEN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 63,487 shares.
Seagen Inc (SGEN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Seagen Inc Insider Transactions
Clay B Siegall Mailing Address
Above is the net worth, insider trading, and ownership report for Clay B Siegall. You might contact Clay B Siegall via mailing address: 21823 30th Dr Se, Bothell Wa 98021.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
